G
Genevieve Neal-Perry
Professor
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
Sep 17, 2026
Hot flashes and hormone therapy: the science of perimenopause
10:47
10:58
11:23
11:44
11:51

Flora LichtmanHOST
Genevieve, can you give me a sort of short version of why it was taboo and what's changed in the last couple years?

Genevieve Neal-PerryGUEST
[laughs] So, you know, the Women's Health Initiative, the WHI study, was a really important study, and it was designed to help us understand whether estrogen hormone therapy was associated with breast cancer, whether we had improvement in terms of neurocognition, and whether we, um, had a heart benefit.

Genevieve Neal-PerryGUEST
And it was designed to look at women who were older, right? And it did what it was intended to do in terms of the study, and we, you know, we found that it wasn't cardio protective because for many years women were told even if you, you know, you've been menopausal for 15 years, you should start estrogen because it's, it's, um, cardio protective.

Genevieve Neal-PerryGUEST
So it found that that wasn't the case and, you know, we found that, um-

Genevieve Neal-PerryGUEST
And it wasn't helping cognition in, in older women and, you know, and there was an inc- uh, an increased risk for, um, breast cancer, which by the way, was not the first time this was demonstrated.